These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

297 related items for PubMed ID: 19657981

  • 1. Anterior uveitis complicating zoledronic acid infusion.
    Colucci A, Modorati G, Miserocchi E, Di Matteo F, Rama P.
    Ocul Immunol Inflamm; 2009; 17(4):267-8. PubMed ID: 19657981
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Unilateral anterior uveitis complicating zoledronic acid therapy in prostate cancer.
    Banal F, Briot K, Ayoub G, Dougados M, Roux C.
    J Rheumatol; 2008 Dec; 35(12):2458-9. PubMed ID: 19040323
    [No Abstract] [Full Text] [Related]

  • 6. A multicenter and open label clinical trial of zoledronic acid 4 mg in patients with hypercalcemia of malignancy.
    Kawada K, Minami H, Okabe K, Watanabe T, Inoue K, Sawamura M, Yagi Y, Sasaki T, Takashima S.
    Jpn J Clin Oncol; 2005 Jan; 35(1):28-33. PubMed ID: 15681601
    [Abstract] [Full Text] [Related]

  • 7. Diffuse ocular and orbital inflammation after zoledronate infusion-case report and review of the literature.
    Umunakwe OC, Herren D, Kim SJ, Kohanim S.
    Digit J Ophthalmol; 2017 Jan; 23(4):18-21. PubMed ID: 29403337
    [Abstract] [Full Text] [Related]

  • 8. The Effects of Re-challenge in Patients with a History of Acute Anterior Uveitis Following Intravenous Zoledronate.
    Patel DV, Horne A, Mihov B, Stewart A, Reid IR, McGhee CN.
    Calcif Tissue Int; 2015 Jul; 97(1):58-61. PubMed ID: 26001948
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Bilateral acute uveitis and conjunctivitis after zoledronic acid therapy.
    Durnian JM, Olujohungbe A, Kyle G.
    Eye (Lond); 2005 Feb; 19(2):221-2. PubMed ID: 15258605
    [No Abstract] [Full Text] [Related]

  • 11. Renal safety of 1-hour pamidronate infusion for breast cancer and multiple myeloma patients: comparison between clinical trials and population-based database.
    de Lemos ML, Taylor SC, Barnett JB, Hu F, Levin A, Moravan V, O'Reilly SE.
    J Oncol Pharm Pract; 2006 Dec; 12(4):193-9. PubMed ID: 17156591
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. "Safety and convenience of a 15-minute infusion of zoledronic acid": not so safe.
    Lugassy G.
    Oncologist; 2005 May; 10(5):309-10; author reply 311-2. PubMed ID: 15851782
    [No Abstract] [Full Text] [Related]

  • 16. Bisphosphonate-associated orbital inflammatory disease and uveitis anterior--a case report and review.
    Böni C, Kordic H, Chaloupka K.
    Klin Monbl Augenheilkd; 2013 Apr; 230(4):367-9. PubMed ID: 23629782
    [Abstract] [Full Text] [Related]

  • 17. Bilateral Acute Anterior Uveitis and Conjunctivitis following Intravenous Zoledronic Acid.
    Chatterjee S, Agrawal D.
    J Assoc Physicians India; 2017 Jul; 65(7):110-111. PubMed ID: 28792180
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.